Skandinaviska Enskilda Banken AB (publ) - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$806
-44.9%
35,9450.0%0.01%
-50.0%
Q2 2023$1,462
-16.0%
35,9450.0%0.01%
-16.7%
Q1 2023$1,741
+21.1%
35,945
-4.6%
0.01%
+9.1%
Q4 2022$1,438
-99.9%
37,676
-5.5%
0.01%
-26.7%
Q3 2022$2,001,000
+25.3%
39,8590.0%0.02%
+25.0%
Q2 2022$1,597,000
+7.4%
39,8590.0%0.01%
+33.3%
Q1 2022$1,487,000
-6.9%
39,8590.0%0.01%
+12.5%
Q4 2021$1,598,000
+7.8%
39,8590.0%0.01%0.0%
Q3 2021$1,483,000
-12.0%
39,8590.0%0.01%
-20.0%
Q2 2021$1,685,000
+20.4%
39,859
+34.8%
0.01%
+11.1%
Q1 2021$1,400,00029,5750.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders